CAM
MGNX icon

Cresset Asset Management’s MacroGenics MGNX Stock Holding History

Cresset Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Buy
+25,828
New +$97.7K ﹤0.01% 1648
2025
Q2 		– Sell
-17,548
Closed -$22.3K – 1650
2025
Q1 		$22.3K Sell
17,548
-1,169
-6% -$3.05K ﹤0.01% 1689
2024
Q4 		$60.8K Sell
18,717
-2,603
-12% -$9.38K ﹤0.01% 1653
2024
Q3 		$70.1K Buy
+21,320
New +$83.1K ﹤0.01% 2069

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Cresset Asset Management's MGNX Position: Q2 2026 in Review

Cresset Asset Management opened a new position in MacroGenics (MGNX) in Q2 2026: 25,828 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #1648 among its holdings. This is a return to the name: Cresset Asset Management previously reported a position in MGNX as recently as Q1 2025.

Cresset Asset Management first reported a position in MGNX in Q3 2024 and has held it in 4 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Cresset Asset Management held 25,828 shares of MacroGenics worth $119K as of Q2 2026.
  • MacroGenics was a new Cresset Asset Management position in Q2 2026.
  • MacroGenics made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1648 holding.
  • Cresset Asset Management first reported a position in MacroGenics in Q3 2024 and has held it in 4 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.